Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Craig Venter, Ted Goldstein, Jeffrey Busch, John Brugmann, Mick Ruxin, More

Craig Venter

Craig Venter announced that he is retiring from Human Longevity, the company he cofounded and where he serves as chairman and CEO. Venter said in a tweet that he will be returning to the J. Craig Venter Institute, which he founded in 2006, "to continue my work."

Ted Goldstein

Precision medicine informatics company GNS Healthcare has named bioinformatician and biomedical engineer Ted Goldstein to its strategic advisory board. Goldstein, who serves as the scientific program director of computational health at the University of California, San Francisco, is leading the development of a machine learning-based comprehensive cancer diagnosis and treatment model for the university. He previously served as vice president of developer tools at Apple and as an e-commerce hardware developer for Sun Microsystems.

Jeffrey Busch, John Brugmann, Mick Ruxin

Avant Diagnostics has appointed Jeffrey Busch as chairman of its board of directors and John Brugmann as a director on the board. In addition, Mick Ruxin has joined the firm as CEO, resident, and board member.

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.